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Permanent pacing, being non physiological, often results in ventricular dysfunction over
time. Narrower paced QRS duration from pacing the right ventricular outflow tract septum,
might result in relatively preserved ventricular function over long term follow up.
Copyright © 2015, Indian Heart Rhythm Society. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).Introduction
More than 50 years have passed since first successful human
implantation of an external cardiac pacemaker [1]. However,
still the optimal pacing mode and pacing site remains elusive.
The normal myocardial activation is through the conduction
system resulting in synchronous activation of both ventricles.
Though myocardial stimulation achieved by pacing outside
the conduction axis results in efficient contractions with
impressive haemodynamic results, it is not physiological.
Such a pacing generates awave frontwhich propagates slowly
through the myocardium leading to ventricular dyssyn-
chrony. This slow conduction through myocardium results iniology, AIIMS, New Delhi
com (G. Sharma).
eart Rhythm Society.
ythm Society. Production
mons.org/licenses/by-ncintraventricular conduction delay (IVCD), manifested on sur-
face electrocardiogram (ECG) by a prolonged QRS duration
(QRSd). Right ventricle (RV) pacing prolongs the surface ECG
QRSd variably depending on the lead position.
Studies have shown that a prolonged QRSd is associated
with increased congestive heart failure (CHF) risk, even in
patients without any overt cardiovascular disease [2,3]. A
prolonged QRSd is also an independent risk factor for sudden
cardiac death (SCD) [4,5]. In patients with CHF, those with
prolonged QRSd have lower left ventricle ejection fraction
(LVEF), higher LV volumes and protracted course of heart
failure, than in counterparts with shorter QRSd, indicating
more advanced cardiac pathology [6e11]., India.
and hosting by Elsevier B.V. This is an open access article under
-nd/4.0/).
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pacedQRSduration (p-QRSd)mightbeusedasauseful indicator
for impairedLVfunction [12e15] andcanpredict theoccurrence
of congestive heart failure [14,16e18]. Though various imaging
modalities like 2D transthoracic echocardiogram (2D-TTE), 3D
transthoracic echocardiogram (3D-TTE), magnetic resonance
imaging (MRI) and radionuclide imaging (RNI) studies can be
utilized to measure LV function, each modality has its own
merits and demerits. Unlike echocardiography radionuclide
imaging is objective and has a good correlation with MRI in
measuring LV functionand volumes [19]. Radionuclide imaging
studies are safe, feasible, and readily available atmany centres
and scores over MRI in post pacemaker patients due to the
concerns of MRI incompatibility.
The relationship between p-QRSd and left ventricular (LV)
function using equilibrium radionuclide angiography (ERNA)
in patients with permanent RV pacing has not been previously
studied in a comprehensivemanner.We intended to study the
association between p-QRSd and LV function measured using
ERNA in patients with permanent RV pacing who were docu-
mented to have normal baseline LV function.Methods
Seventy consecutive patients who underwent permanent
pacemaker implantation and had normal LV function at
baseline were prospectively enrolled. Informed written con-
sent was obtained from all participants. The study was
approved by the Institute Ethics Committee. Patients with
prior LV dysfunction (LV function less than 50% assessed by
2D TTE), those who required cardiac resynchronization ther-
apy (CRT), those in atrial fibrillation, those with structural
heart defects and those who were unable to provide informed
consent were excluded from the study.Pacemaker implantation protocol
We utilized fluoroscopically guided axillary vein puncture in
all these patients. The details of the procedural technique
have been described by our group in a previous study [20]. The
type of pacemaker to be implanted whether dual or single
chamber was decided by the patient and the treating physi-
cian. The position of lead implantation and site in RV was
decided by the operator. Site of implantation of pacing lead at
RV apex (RVA) or RV outflow tract (RVOT) was noted in all
patients. The 40-degree right anterior oblique (RAO) view
arbitrary divides the RV in to high RVOT, low RVOT, mid
septum, low septum and RV apex. Bundle of HIS forms the
inferior margin and pulmonary valve forms the superior
margin of RVOT, which is further arbitrary, divided in to two
equal areas, high and low RVOT. Part of RV below the bundle
of HIS forms the septum, which is again equally divided into
mid and low septum [21]. Cine fluoroscopy images of final lead
positions were recorded in all patients.
Intra-procedural lead stimulation threshold was checked
in all cases at a pulse width of 0.5 ms using a pacing system
analyser. Ventricular threshold of 2.0 V and R-wave sensing
5 mV were considered acceptable pacing parameters.Equilibrium radionuclide angiography protocol
All patients underwent Technetium-99m labelled Red Blood
Cells (Tc-99m RBC) ERNA studies both at rest (with pacing
parameters as at the time of pacemaker implantation) and
under forced cardiac pacing at 100 beats per minute (bpm).
Forced pacing at 100 bpmwas conducted to ensure uniformity
so that p-QRSd does not vary owing of different pacing rates.
The RBC labelling was performed by 0.5e0.9 mg (15 mg/Kg of
body weight) of stannous ions as stannous chloride via intra-
venous route. The stannous ions prime the RBCs, which were
tagged with 15e20 mCi (550e740 MBq) of Tc99m pertechnate
injected intravenously. Rest ERNA acquisition was performed
10e15 min later with a dual head gamma camera (Infinia
Hawkeye 7; General Electric Company, Milwaukee, Wisconsin, USA)
fitted with a Low energy general purpose (LEGP) collimator.
Images were acquired in left anterior oblique view (for best
septal view, approx. LAO 40e50) using energy discrimination
centered on 140 ± 10% kilo electron volts (keV). The projection
was gated with the ECG to get 32 frames spanning the cardiac
cycle. Images were acquired in 64*64 matrix, with a zoom
factor of 1.6; the view was acquired for 300e400 s (approx.
500e600 Kilo counts). Elimination of ventricular premature
beats was obtained with a window threshold of 15% around
the mean RR interval during acquisition of projections.
Extrasystolic and post extrasystolic cycles were excluded.
Each patient had baseline rest (S0) & baseline forced paced
(pS0) study within 5 days of pacemaker implantation with
follow-up studies at 6 month (rest S1 and forced paced pS1)
and 12 month (rest S2 and forced paced pS2). The rest study
was conducted with default pacing parameters, while the
forced paced study was conducted at a forced pacing rate of
100 bpm. LV ejection fraction (LVEF) was analysed as a
parameter of LV function.
Paced QRS duration on surface ECG was measured in all
patients at a forced pacing rate of 100 bpm, after recording ECG
strips at a paper speed of 50 mm per sec to minimize error.
Patientswere divided into two groups based on p-QRSdusing a
cutoff value of 130 ms (ms). Group 1 included patients with
PQRSD130mswhile group 2 had PQRSD>130ms.We studied
various parameters between these two groups including LV
function, the percentage of ventricular pacing, development of
atrial fibrillation and any other pacemaker related events
documented during routine pacemaker interrogation.
Statistical analysis
Data are presented as mean with standard deviations or
median with ranges where appropriate. Chi Square test was
used for comparison of categorical (qualitative) data be-
tween groups. For normally distributed continuous vari-
ables, the Student's t-test was applied for comparison
between two groups. If variables did not follow normal
distribution, the ManneWhitney test was applied. Statisti-
cal significance was analysed using the Paired T test for
comparisons of paired quantitative data if the data was
normally distributed. If the data was not normally distrib-
uted, Wilcoxon log rank test was used for analysis. Com-
parison of repeated measurements was done using general
linear model (One-way analysis of variance was used to
Table 1 e Baseline characteristics of study population.
Characteristic Total (N ¼ 48) N (%)
Age (years) 56.21 ± 12.04
Sex Male 28 58.33
pQRSd (ms) 141.46 ± 22.54
Indication CHB 44 91.77
SSS 4 8.33
Pacing Dual chamber 33 68.75
Single chamber 15 31.25
Site RVOT 27 56.25
RVA 21 43.75
Baseline LVEF 56.80 ± 4.53
pQRSd: paced QRS duration, CHB: complete heart block, SSS: sick
sinus syndrome, RVOT: right ventricle outflow tract, RVA: right
ventricle apex, LVEF: left ventricle ejection fraction.
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between groups, followed by a post hoc bonferroni's test, as
appropriate.). A p value of <0.05 was considered as signifi-
cant. All the data analyses were performed using the sta-
tistical software packages SPSS 11.5 (SPSS Inc., Chicago,
Illinois, USA).Results
Out of seventy patients who were enrolled in the study, forty-
eight who completed 12 months of follow up were included in
the final analysis. The baseline characteristics of the study
population are shown in Table 1. Mean age of the patients was
56.21 ± 12.04 years with 28 male patients (58.33%). Thirteen
patients were lost to follow-up or did not adhere to the
schedule of study protocol and nine patients whose studies
failed quality control due to high percentage of rejected beats;
were excluded from the final analysis.
All patients had successful, fluoroscopically guided axillary
vein puncture without any procedural complication. Com-
plete heart block was the most common indication for pacing
(44/48 patients; 91.66%). Thirty three patients (68.75%)Table 2 e Characteristics between group 1 (pQRSD ≤130 ms) a
Parameters Group 1 (N
Mean ±
Age 54.79 ± 14.62
Sex (male/female) 8/11
pQRSd (msec) 120 ± 7.4
Mode Dual chamber 16
Single chamber 3
Site RVOT 14
Apical 5
Hypertension 7
Diabetes 1
Coronary Artery Disease 1
Valvular heart disease 0
Ventricular Pacing (%) 53.8 ± 43.0
LVEF (Baseline %) 57.2 ± 4.1
LVEF (at 12 months %) 54.8 ± 7.3
LVEF (at paced rate 100 bpm) baseline % 56.6 ± 5.5
LVEF (at paced rate 100 bpm) 1 Year % 54.9 ± 7.5
Paired difference in LVEF at 1 year % 1.67 ± 4.70received dual chamber pacemaker; while the rest had isolated
RV pacing. 28 (58.33%) patients received RVOT pacing. Mean
pQRSd of the study population was 141.46 ± 22.54 ms.
Nineteen patients had a pQRSd 130 ms (Group 1) and 29
patients had pQRSd >130 ms (Group 2). Baseline characteris-
tics were similar between the two groups with respect to age,
sex, percentage of ventricular pacing, presence of predispos-
ing cardiac disease like hypertension, coronary artery disease,
valvular heart disease and diabetes mellitus (Table 2). There
was no significant difference in the number of patients with
respect to dual v/s single chamber pacemaker between the
two groups. Left ventricular ejection fraction (LVEF) at base-
line did not differ significantly between both groups
(57.2 ± 4.1% vs 56.5 ± 4.8%; P ¼ 0.615). It was observed that the
majority of patients (14/19, 73.68%) in group 1 had pacing leads
implanted in the RVOT, as compared to 14/29 (48.27%) in group
2. pQRSd (mean ± S.D.) was significantly greater in group 2
than in group 1 (155.5 ± 17.31 ms vs. 120 ± 7.45 ms; p < 0.0001)
(Fig. 1). At the end of one year follow-up, a statistically sig-
nificant decline in LVEFwas observed in group 2 (54.7 ± 5.6% to
52.9 ± 6.3%; P ¼ 0.031); but LVEF was found to be preserved in
group 1 (56.6 ± 5.5% to 54.9 ± 7.5%; P ¼ 0.151) (Fig. 2). No sig-
nificant difference in LVEF between the two groups was
observed after one year of follow-up (54.8 ± 7.3 v/s 52.3 ± 6.9%,
p ¼ 0.946). However when paired differences between both
groups were analysed, the change in LVEF was not found to be
significant. A small study group could be the possible reason
for this discrepancy. None of the patient in either group
developed new onset atrial fibrillation, congestive heart fail-
ure or had acute coronary syndrome during this period.Discussion
Paced QRS duration and left ventricular function
Studies have consistently shown that narrow paced QRS
duration is associated with preservation of LV function and
reduced incidence of heart failure events. Sumiyoshi et al. [12]nd group 2 (pQRSd >130 ms).
¼ 19)
S.D
Group 2 (n ¼ 29)
Mean ± S.D
P value
57.13 ± 10.18 p ¼ 0.515
20/9 p ¼ 0.065
155.5 ± 17.3 P < 0.0001
17 P ¼ 0.061
12
14 P ¼ 0.080
15
16 P ¼ 0.250
5 P ¼ 0.381
6 P ¼ 0.219
2 P ¼ 0.512
63.1 ± 44.7 P ¼ 0.541
56.5 ± 4.8 P ¼ 0.615
52.3 ± 6.9 P ¼ 0.946
P ¼ 0.151 54.7 ± 5.6 P ¼ 0.031 P ¼ 0.272
52.9 ± 6.3 P ¼ 0.239
1.75 ± 4.07 P ¼ 0.95
Fig. 1 e A. Electrocardiogram of a patient in group 1 with
RVOT pacing having narrow paced QRS duration (pQRSd) of
<130 ms. B. Electrocardiogram of patient in group 2 with
RV apical pacing having pQRSd of >130 ms.
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permanent pacemaker for atrio-ventricular block. Patients
with pQRSd of more than 180 ms had significantly high inci-
dence of underlying heart disease (83% vs 32%, p < 0.01),
reduced LVEF (49 ± 17% vs 68 ± 10%, p < 0.01) and elevated LV
end diastolic dimension (57.1 ± 7.9 mm vs 48.5 ± 5.6 mm,Fig. 2 e There is significant fall in left ventricle ejection
fraction (LVEF) in group 2 with paced QRD duration (pQRSd)
>130 ms (54.7 ± 5.6 to 52.9 ± 6.3, p¼ 0.031). Whereas there
is insignificant fall in LVEF in group 1 with pQRSd ≤130 ms
(56.6 ± 5.5 to 54.9 ± 7.5, p ¼ 0.151).p < 0.01), as compared to those with pQRSd of less than
180 ms. The authors concluded that prolonged pQRSd is
associated with more advanced underlying heart disease and
can be valuable in predicting impaired LV systolic function. A
case control study in patients receiving permanent RV apical
pacing for at least 1 year [13] showed pQRSd to have significant
negative correlation with LVEF (b ¼ 109.25, P < 0.001) and
significant positive correlations with LVDd (LV end-diastolic)
and LVDs (LV end-systolic) dimensions (b ¼ 1.59 and 1.54,
respectively; P < 0.001). A pQRSd value of 200 ms was 71.72%
sensitive and 86.71% specific to detect LV systolic dysfunction.
Similar results were reiterated by Yangang et al. [22].
Miyoshi et al. [14] prospectively analysed p-QRSd during RV
pacing in 92 permanently paced patients over ameanperiod of
53 ± 16 months. Prolonged p-QRSd using a cut-off valve of
190ms significantly predicted the development of CHF(46.6%
v/s 11.6%, p < 0.05) and was associated with significant wors-
ening of LV function parameters, with lower LVEF (53.0± 14.6%
vs 62.8 ± 12.3%, p < 0.05), higher LVDd (60.0 ± 10.4 mm v/s
48.9 ± 7.4mm, p < 0.05) and LVDs (43.2 ± 11.5 vs 32.1 ± 8.1 mm,
p < 0.05) dimensions, as compared to those with pQRSd of less
than 190 ms A recent observational cohort study PREDICT-HF
[16] enrolled 194 patients receiving RV apical pacing and
stratified them to groups based on pQRSd. Over amean follow-
up period of 3 years significantly higher number of patients
(56.8%) with pQRSd >190 ms developed overt heart failure as
compared to 9.4% with pQRSd <160 ms, p < 0.001. Linear
regression analyses showed falling LVEF to correlate with
prolonged pQRSd (RR ¼ 0.423, p < 0.05).
The prolonged pQRSd results in haemodynamic deterio-
ration not only in long term but also results in acute haemo-
dynamic worsening. Hong et al. [23] studied the acute
haemodynamic consequences of RV pacing and its relation-
ship with pQRSd. They found that systolic blood pressure
(SBP) decrease during pacing was larger in the group exhibit-
ing pQRSd of greater than 140 msec. The SBP decrease during
pacing showed significant correlation with pQRSd (r ¼ 0.500,
p ¼ 0.001). They concluded that ventricular pacing should be
performed from a site with narrowest pQRSd possible, pref-
erably <140 msec.
Consistent with prior studies, our study also shows that in
patients with permanent RV pacing and normal baseline LV
function, presence of narrow paced QRS duration (pQRSd
<130 ms) is associated with preservation of LV function at 12
month follow-up. However the change of LVEF in group 2 with
pQRSd >130ms in our study groupwas less than that reported
by previous authors. We also did not found any event of
congestive heart failure at 12 month follow-up. These obser-
vations could be explained by the various factors. Firstly, RV
pacing induced adverse left ventricular remodelling in pa-
tients with normal baseline LV function may manifest after a
long time [24,25]. A shorter follow-up period of 12 months as
compared to other clinical studies explains this nil incidence
of new onset heart failure and relative preservation of LVEF in
our study group. Moreover, the mean pQRSd of our study
group (141.46 ± 22.54 ms) was far less than that in other
studies, suggesting far less advanced underlying cardiac dis-
ease in our study population. Prior studies have included a
large number of patients with underlying heart disease as
compared to relatively healthy population in our study. Our
i n d i a n p a c i n g and e l e c t r o p h y s i o l o g y j o u rn a l 1 5 ( 2 0 1 5 ) 9 0e9 594study population was relatively young as compared to the
western studies, which could have affected these outcomes.
Finally there were no events of acute coronary syndrome or
development of new onset atrial fibrillation in the follow-up
period which could have predisposed to LV dysfunction.
Role of paced site and QRS duration
Site of RV Pacing determines the myocardial activation
sequence, and thus pacing at different RV sites result in varied
paced QRS duration. As prolong pQRSd is associated with
worsening of LV function and higher risk of heart failure
hospitalisations, right ventricular outflow tract (RVOT) pacing
has been proposed as an alternative RV pacing site to preserve
LV function [26,27].
Nakmuraet al. [21] studied theeffect onpQRSdonpacingRV
from five different sites in 50 patients. They divided RV pacing
sites into high RVOT, low RVOT, mid septum, low septum and
RVapex. The pQRSdwas significantly shorter during lowRVOT
(143 ± 17ms) andmid-septal (151 ± 20ms) pacing compared to
apical (167 ± 18 ms) pacing site (p < 0.001). QRS duration was
shortest when the septum was paced in the right ventricle.
However in 32% patients, pQRSd was no different with low-
RVOT, mid-septal, or apical pacing. The authors concluded
that low RVOT or mid septal pacing is likely to lead to less
dyssynchrony than RV apical pacing in almost 70% of the pa-
tients requiring RV pacing. A recent study [28] reported signif-
icantly longer pQRSd in patients receiving the right ventricular
apical pacing (160 ± 15 ms) as compared to RVOT (140 ± 15 ms,
P ¼ 0.02) and RV inflow tract pacing (133 ± 17 ms, P < 0.001).
In our study, presence of majority of leads at RVOT (14/19)
in patients with narrow pQRSd <130 ms, suggests that RVOT
pacing might well be associated with less prolongation of
pQRSd and lesser deterioration in LV function as compared to
RVA pacing. Although alternate site RV pacing leads to narrow
pQRSd as compared to RV apical pacing, long term clinical
benefit of non-apical pacing are still not completely clear.
Though there are studies which show clinical benefit of
alternate site RV pacing at para-Hisian [29], septal [24] and
RVOT [30] sites as compared to RV apical position, there are
others which refute this notion [31,32]. Most of these are small
non randomized studieswith relatively short follow-up period
and variable clinical endpoints, making interpretation diffi-
cult. Moreover most studies have used echocardiography as
imaging modality to follow-up changes in LV function, which
is highly subjective and is bound to have inter as well as intra
observer variability. Three on-going large randomized control
trials (PROTECT PACE, RASP, and OPTIMISE RV) randomizing
patients to apical versus septal pacing,may shed light on issue
of significance of alternate RV pacing site in patients requiring
long term RV pacing [33].Limitations
This was a single centre non randomized observational
study involving small study group with a relatively short
follow-up duration. Though Equilibrium radionuclide angi-
ography (ERNA) derived LV function was assessed by inde-
pendent observers having no access to other patient data,still the potential of observer bias remains. Equilibrium
radionuclide angiography (ERNA) findings were not vali-
dated against routinely used modality for assessment of LV
function like echocardiography. However, since same im-
aging modality was used in follow-up, each patient served
as his/her own control and therefore, this was not
mandatory. The study exclusively included patients with
normal baseline LV function, so whether the findings of this
study are applicable to patients with LV dysfunction re-
mains an issue for further investigation. Though the
change in LVEF at 1 year when both groups were compared
was significant, there was no significant change in LVEF
when paired difference in LVEF was analysed. This
discrepancy is a major limitation of this study which could
be explained by a small sample size. May be a larger pro-
spective study with longer follow-up address this anomaly.Conclusion
Equilibrium radionuclide angiography (ERNA) can be used for
quantitative assessment of left ventricular ejection fraction in
patients with permanent pacemaker and provides reliable
objective assessment of LV function in follow-up studies.
Paced QRS (pQRSd) duration of 130 ms may be associated
with significant decline in left ventricular ejection fraction
over a period of 1 year as compared to those with pQRSd of
<130 ms. RVOT pacing might be associated with less prolon-
gation of pQRSd and lesser deterioration in LV function as
compared to RVA pacing, and should bemore fully assessed in
a large randomized control trial setting.Conflict of interests
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